title: Comment on: Ramos-Zavala et al. Effect of diacerein on insulin secretion and metabolic control in drug-naïve patients with type 2 diabetes: a randomized clinical trial. Diabetes Care 2011;34:1591-1594.
authors.forename: Natália
authors.initials: N
authors.lastname: Tobar
authors.forename: Alexandre G
authors.initials: AG
authors.lastname: Oliveira
authors.forename: Dioze
authors.initials: D
authors.lastname: Guadagnini
authors.forename: Renata A
authors.initials: RA
authors.lastname: Bagarolli
authors.forename: Guilherme Z
authors.initials: GZ
authors.lastname: Rocha
authors.forename: Tiago G
authors.initials: TG
authors.lastname: Araujo
authors.forename: Patrícia O
authors.initials: PO
authors.lastname: Prada
authors.forename: Mario J A
authors.initials: MJ
authors.lastname: Saad
mesh_terms: D000880:Anthraquinones / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male
chemical_list: D000880:Anthraquinones; D001786:Blood Glucose; D007328:Insulin